Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Kim SJ, Seo HY, Choi JG, Sul HR, Sung HJ, Park KH, Choi IK, Oh SC, Yoon SY, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
Kim SJ, et al. Among authors: kim yh, kim bs, kim js.
Cancer Chemother Pharmacol. 2006 Apr;57(4):436-42. doi: 10.1007/s00280-005-0067-7. Epub 2005 Jul 28.
Cancer Chemother Pharmacol. 2006.
PMID: 16049620
Clinical Trial.